Equilibrium phase MR angiography of the aortic arch and abdominal vasculature with the blood pool contrast agent CMD-A2-Gd-DOTA in pigs

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 6, 1999, Pages 777-785

  Kroft, Lucia J M ^a   Doornbos, Joost ^a   Benderbous, Soraya ^b   De Roos, Albert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Laboratoire Guerbet   (France)

Author keywords

Blood pool; CMD A2 Gd DOTA; Contrast agents; Gadolinium; Macromolecule; Magnetic resonance angiography

Indexed keywords

CONTRAST MEDIUM; MEGLUMINE CARBOXYMETHYLDEXTRAN ETHYLENEDIAMINO GADOTERATE; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; AORTA ARCH; ARTICLE; FEMALE; IMAGE ANALYSIS; IMAGE QUALITY; INFERIOR CAVA VEIN; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RENAL ARTERY; SIGNAL NOISE RATIO; SIGNAL PROCESSING;

ABDOMEN; ANIMALS; AORTA, THORACIC; BLOOD VESSELS; CONTRAST MEDIA; GADOLINIUM; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; ORGANOMETALLIC COMPOUNDS; SWINE;

EID: 0033029721     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199906)9:6<777::AID-JMRI4>3.0.CO;2-Y     Document Type: Article

References (34)

1. Lossef SV, Rajan SS, Patt RH, et al. Gadolinium-enhanced magnitude contrast MR angiography of popliteal and tibial arteries. Radiology 1992;184:349-355.
2. Marchal G, Michiels J, Bosmans H, Van Hecke P. Contrast-enhanced MRA of the brain. J Comput Assist Tomogr 1992;16: 25-29.
3. Lin W, Haacke EM, Smith AS, Clampitt ME. Gadolinium-enhanced high-resolution MR angiography with adaptive vessel tracking: preliminary results in the intracranial circulation. J Magn Reson Imaging 1992;2:277-284.
4. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994; 191:155-164.
5. Corot C, Schaefer M, Beauté S, et al. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA; a new paramagnetic dextran polymer. Acta Radiol 1997;38:91-99.
6. Creasy JL, Price RR, Presbrey T, Goins D, Partain CL, Kessler RM. Gadolinium-enhanced MR angiography. Radiology 1990;175:280-283.
7. Chakeres DW, Schmalbrock P, Brogan M. Yuan C, Cohen L. Normal venous anatomy of the brain: demonstration with gadopentetate dimeglumine in enhanced 3-D MR angiography. AJR 1990;156:161-172.
8. Kouwenhoven M. Contrast-enhanced MR angiography: methods, limitations and possibilities. Acta Radiol 1997;38:57-67.
9. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR 1995;166:73-77.
10. Anzai Y, Prince MR, Chenevert TL, et al. MR Angiography with an ultrasmall superparamagnetic iron oxide blood pool agent, J Magn Reson Imaging 1997;7:209-214.
11. Stillman AE, Wilke N, Li D, Haacke M, McLachlan S. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients. J Comput Assist Tomogr 1996;20:51-55.
12. Benderbous S, Corot C, Jacobs P, Bonnemain B. Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. Acad Radiol 1996;3(suppl):S292-294.
13. Loubeyre P, Zhao S, Canet E, Abidi H, Benderbous S, Revel D. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits. J Magn Reson Imaging 1997;7:958-962.
14. Prince MR, Narasimham DL, Stanley JC. et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
15. Van der Geest RJ, Buller VGM, Jansen E, et al. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short axis MR images. J Comput Assist Tomogr 1997;21:756-765.
16. Neter J, Wasserman W, Kutner MH. In: Applied linear statistic models. Chapter 28 P1035-1082 Repeated measures and related design. Irwin, Homewood IL; 1990.
17. Schmiedl U, Ogan MD, Moseley ME, Brasch RC. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. AJR 1986;147:1263-1270.
18. Ogan MD, Schmiedl U, Moseley E, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987;22:665-671.
19. Wang S-C, Wikström MG, White DL, et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Radiology 1990;175:483-488.
20. Loubeyre P, Canet E, Zhao S, Benderbous S, Amiel M, Revel D. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography; experimental studies in rabbits. Invest Radiol 1996;31:288-293.
21. Marchal G, Bosmans H, Van Hecke P, et al. MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits. AJR 1990;155:407-411.
22. Bourne MW, Magerun L, Hylton N, et al. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body. J Magn Reson Imaging 1996;6:305-310.
23. Lauffer RB, Parmelee DJ, Ouellet HS, et al. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Acad Radiol 1996;3:S356-S358.
24. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: Albumin-targeted contrast agent for MR angiography. Radiology 1998;207: 529-538.
25. Grist TM, Korosec FR, Peters DC. et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998;207:539-544.
26. Parmelee DJ, Walovitch RC, Ouellet HS. Randall B, Lauffer B. Preclinical evaluations of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997;32:741-747.
27. Vexler VS, Berthezène Y, Wilfe CL, et al. Magnetic resonance imaging demonstration of pharmacologic-induced myocardial vasodilatation using a macromolecular gadolinium contrast agent. Invest Radiol 1992;27:935-941.
28. Baxter A, Melnikoff S. Stites DP, Brasch RC. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Invest Radiol 1991;26:1035-1040.
29. Rocklage SM, Worah D, Kim S-H. Metal ion release from paramagnetic chelates: What is tolerable? Magn Reson Med 1991;22:216-221.
30. Yamashita Y, Mitsuzaki K, Tang Y, Namimoto T, Takahashi M. Gadolinium-enhanced breath-hold three-dimensional time-of-flight MR angiography of the abdominal and pelvic vessels: the value of ultrafast MP-RAGE sequences. J Magn Reson Imaging 1997;7:623-628.
31. Holland GA, Dougherty L, Carpenter JP, et al. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries. AJR 1996;166:971-981.
32. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology 1996;201:705-710.
33. Tello R, Thomson KR, Witte D, Becker GJ, Tress BM. Standard dose Gd-DTPA dynamic MR of renal arteries. J Magn Reson Imaging 1998;8:421-426.
34. Brown DG, Riederer SJ. Contrast-to-noise ratios in maximum intensity projection images. Magn Reson Med 1992;23:130-137.